Health

In this short video, Chris Thompson of eResearch talks about DCM’s merger with Moore Canada Corporation and eResearch’s 10-page Equity Research Report that covers an in-depth analysis of the company and a detailed overview of the acquisition, and the Q4/2022 financial results. [more]

We have written a 10-page Update Report on DATA Communications Management(DCM), a Canadian-based communications and marketing solutions provider that offers comprehensive online and offline communications and marketing solutions to businesses. The update report provides highlights of the Company’s recent announcements to acquire RRD Canada and preliminary full-year financial results for 2022 with revenue in the range of $270 million to $274 million, a 15% to 16.5% increase compared with 2021. [more]

Foodtastic announced that it has entered into an agreement to acquire Freshii Inc. (TSX:FRII) . Under the terms of the agreement, Foodtastic will purchase all of Freshii’s shares for $2.30 in cash per share, totaling approximately $74.4 million. This price represents a premium of 148% over Freshii’s 20-day volume-weighted average price per share as of December 16, 2022, and a 142% premium over the closing price on the same date. [more]

In this short video, Chris Thompson of eResearch talks about DCM’s double-digit quarterly revenue growth and strong EBITDA in Q3/2023 and eResearch’s 18-page Equity Research Report that covers an in-depth analysis of the company and a detailed overview of its Q3/2022 financial results. [more]

We have written an 18-page Update Report on DATA Communications Management, a Canadian-based communications and marketing solutions provider that offers comprehensive online and offline communications and marketing solutions to businesses. The update report provides highlights of the Company’s Q3/2022 financials and a full summary of our valuation methodology. We increased the Target Price to $4.50 from $4.20. [more]

The size of the market for treatable mental health disorders is currently $300 billion in the U.S. and is expected to grow over the next five years. An opportunity exists for clinical-stage companies to commercialize their operations with alternative treatment methods to fill this need. The following article describes the commercialization developments, market capitalizations, and price performances of 6 companies in the industry. [more]

The six main constituents were down 26.9% in April and are now down 54.2% YTD. The next four constituents were down 23.3% in April and are now down 47.1% YTD. [more]

The munKNEE Pure-Play Plant-Based Food Stocks Index is down 17.4% so far this month and is now down 45.9% YTD and down 77.5% from its peak in 2021. [more]